Tailored Life Science Insurance

Through appointed retail and wholesale brokers, our industry specialists offer comprehensive life science insurance solutions globally.

Insurance Solutions By Life Science Specialists

In true partnership with our agents, we offer the following life science insurance solutions, customized to the needs of your clients.

Primary

Primary

Through our LS Prime® and LS Prime® Advantage options, primary insurance coverage is offered as an admitted or non-admitted primary insurance solution.

Excess

Excess

Excess liability coverage of up to $15 million is available to protect a policyholder against unforeseeable catastrophic liability judgments.

Package

Package

Your comprehensive solution, our admitted package product provides premises operations, property, commercial auto, workers compensation, crime, and umbrella coverage.

Multinational

Multinational

Addressing localized needs of customers in more than 90 countries around the world, we offer an integrated global solution through our LS Prime® specialty including Foreign Clinical Trials, Local Products policy placements and Local Admitted Package policies.

Why Berkley Life Sciences

Learn More About Us
Learn More About Us

Helpful Links

-

Partner With Us

Partner With Us

Interested in becoming a Berkley Life Sciences appointed agency? Contact us.

Find an Agent

Find an Agent

Ready for an insurance solution that is tailored to your life science business by life science specialists? Find an agent.

Approved State Filings

Approved State Filings

Explore our approved state filings for our admitted products. Our non-admitted coverages are available in all 50 states.

All states except the following are approved: Alaska, Arkansas, California, Hawaii, Kansas, Minnesota, Montana, New Mexico, New York, North Dakota, Oklahoma, South Dakota, Vermont, Washington State, Wyoming

The Latest in Life Science

Not Just a Claims Adjuster – A Conversation with Cynthia Khin

Not Just a Claims Adjuster – A Conversation with Cynthia Khin

Recently, Magna Legal Services, a company that provides legal support and consulting services, interviewed Berkley Life Sciences Cynthia "Cindy" Khin, Life Sciences Casualty Resolution Director. The following is their conversation about Cindy’s career path and the importance of mock trials.

FDA Draft Guidance for Misinformation – Part 2

FDA Draft Guidance for Misinformation – Part 2

In a previous post, we discussed the FDA’s July 2024 Draft Guidance entitled "Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers" (the "Draft Guidance"). The Draft Guidance suggests a purportedly voluntary pathway for drug and device sponsors, manufacturers, distributors, and other stakeholders legally responsible for the labeling of approved/cleared medical products ("firms") to respond to internet-based posts and comments in a manner consistent with existing product labeling and advertising laws.


A surgeon handles sterilized medical equipment

Preventing Medical Device Shortages Through Improving the United States Sterilization Supply Chain

Both Ethylene Oxide (EtO) and gamma radiation are highly effective sterilizers for medical devices, but they face significant supply chain vulnerabilities that have already led to shortages within the United States. To mitigate these risks and bolster the sterilization supply chain, the FDA recently approved a new “Established Category A” sterilization method and implemented three key programs designed to encourage medical device manufacturers to adopt alternative methods, all within the last five years (FDA, 2024).